Our lab aims to discover new therapeutic strategies to treat human disease by exploring the interface between the genetics and metabolism in clinically relevant systems. Specifically, we are interested in achieving a quantitative understanding of the heterogeneity of cellular metabolism found within tissues in normal and diseased states. To this end, we are developing a combination of different mass-spectrometric methods including imaging, liquid-chromatography, and gas-chromatography mass-spectrometry.